PUBBLICATO IL NUOVO NUMERO DELLA WHO PHARMACEUTICAL NEWSLETTER



WHO PHARMACEUTICALS NEWSLETTER, N. 2
Fonte: WHO. Maggio 2009



E' disponibile il nuovo numero della WHO PHARMACEUTICALS NEWSLETTER dell'Organizzazione Mondiale della Sanità.

In questo numero sono trattati i seguenti argomenti:
Regulatory Matters
• Aliskiren
• Atomoxetine
• Cough and Cold Medicines
• Efalizumab
• Exenatide
• Fenfluramine
• Fluoroquinolones
• Metoclopramide
• Mycophenolate mofetil
• Natalizumab
• Phosphodiesterase type 5 inhibitors
• Zonisamide
Safety of Medicines
• Anticonvulsants
• Antipsychotics
• Black cohosh
• Bisphosphonates
• Botulinum toxin type A
• Clopidogrel
• Dietary supplement containing undeclared drug
• Drotrecogin alfa (activated)
• Ezetimibe
• Methylphenidate
• Non-steroidal anti-inflammatory drugs
• Proton pump inhibitors
• Selective serotonin re-uptake inhibitors
• Tibolone
• Topical anaesthetics
• Unauthorized tanning product
Feature
• 19th Meeting of the Global Advisory Committee on Vaccine Safety, 17-18 December 2008